Foot-and-Mouth Disease (FMD) is a highly contagious viral illness affecting cloven-hoofed animals, caused by the Foot-and-Mouth Disease Virus (FMDV), belonging to the Picornaviridae family, genus Aphthovirus. Serotype A is one of the most epidemiologically relevant, exhibiting wide genetic variability and significant importance for animal health and international trade.
FMDV serotype A is responsible for outbreaks in cattle, swine, sheep, goats, and other susceptible animals. Transmission occurs directly through contact between infected and susceptible animals, and indirectly via aerosols, fomites, vehicles, equipment, clothing, and contaminated animal products. The virus has a high dissemination capacity, including over long distances, especially under favorable environmental conditions.
Clinical manifestations of Foot-and-Mouth Disease include fever, excessive salivation, lameness, and the formation of vesicles in the oral cavity, tongue, gums, lips, snout, udder, and interdigital region. In young animals, infection can result in myocarditis and sudden death. Despite low mortality in adults, morbidity is high, causing severe production impacts.
Prevention and control of Foot-and-Mouth Disease are based on rigorous biosecurity measures, animal movement restrictions, active and passive sanitary surveillance, and official vaccination programs, where applicable. Due to the high antigenic variability of serotype A, the appropriate choice of vaccine strains is essential to ensure immunological efficacy.
Laboratory diagnosis is a central component in the control of Foot-and-Mouth Disease. Molecular methods, such as RT-PCR, allow for rapid and sensitive virus detection, while serological tests assist in epidemiological surveillance and the differentiation between vaccinated and infected animals. Early identification of the involved serotype is fundamental for the adoption of immediate sanitary measures.
Continuous epidemiological surveillance, combined with well-structured contingency plans, is indispensable for preventing the introduction and dissemination of Foot-and-Mouth Disease Virus serotype A. These strategies aim to protect herd health, minimize economic losses, and ensure the maintenance of sanitary status and access to international markets.
In this context, the Bioperfectus Foot-and-Mouth Disease serotype A rapid test serves as a strategic screening tool to support sanitary surveillance in cases of clinical suspicion or animal health emergencies. The application of the rapid test enables the agile identification of suspect animals directly in the field, assisting in the immediate adoption of containment measures such as isolation, property quarantine, animal movement restrictions, and notification to official veterinary services. Thus, the rapid test acts complementarily to confirmatory laboratory methods, contributing to the early detection of outbreaks, the reduction of FMDV serotype A dissemination, and the strengthening of Foot-and-Mouth Disease control strategies.
